Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever Caused by a Newly Identified Virus Strain, Bundibugyo, Uganda, 2007-2008

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Roddy, Paul ^a   Howard, Natasha ^c   van Kerkhove, Maria D ^d   Lutwama, Julius ^e   Wamala, Joseph ^f   Yoti, Zabulon ^g   Colebunders, Robert ^h   Palma, Pedro Pablo ^a   Sterk, Esther ^a   Jeffs, Benjamin ^a   van Herp, Michel ^b   Borchert, Matthias ^c,i  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b MÉDECINS SANS FRONTIÈRES   (Belgium)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^f MINISTRY OF HEALTH   (Uganda)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h UNIVERSITY OF ANTWERP   (Belgium)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ARTEMETHER PLUS BENFLUMETOL; CEFTRIAXONE; CIMETIDINE; CIPROFLOXACIN; PARACETAMOL; QUININE;

ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; ASTHENIA; BLEEDING; BUNDIBUGYO EBOLAVIRUS; CLINICAL ARTICLE; CONJUNCTIVITIS; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DISEASE DURATION; DYSPEPSIA; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; EPIDEMIC; FEMALE; FEVER; FILOVIRUS; HEADACHE; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; MALE; MYALGIA; NAUSEA AND VOMITING; ORAL REHYDRATION THERAPY; PAIN; SURVIVAL RATE; SYMPTOMATOLOGY; UGANDA; VIRUS IDENTIFICATION; VIRUS STRAIN;

ADULT; AGED; CASE MANAGEMENT; COHORT STUDIES; DISEASE OUTBREAKS; EBOLAVIRUS; FEMALE; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; UGANDA; YOUNG ADULT;

EBOLA VIRUS;

EID: 84871689715     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052986     Document Type: Article

References (82)

1. Feldmann H, Geisbert T, Jahrling P, Klenk H, Netesov S, et al. (2004) Filoviridae In: C.MFauquet MAM, JManiloff, UDesselberger, L.ABall, editor. Virus Taxonomy, VIIIth Report of the ICTV. London: Elsevier/Academic Press. pp. 645-653.
2. Kuhn J (2008) Filoviruses: a compendium of 40 years of epidemiological, clinical, and laboratory studies. Wien: Springer.
3. WHO, CDC (1998) Infection Control for Viral Haemorrhagic Fevers in the African Health Care Setting. Available: http://www.who.int/csr/resources/publications/ebola/WHO_EMC_ESR_98_2_EN/en/. Accessed 13 November 2012. Geneva: WHO.
4. Formenty P, Libama F, Epelboin A, Allarangar Y, Leroy E, et al. (2003) [Outbreak of Ebola hemorrhagic fever in the Republic of the Congo, 2003: a new strategy?]. Med Trop (Mars) 63: 291-295.
5. Leroy EM, Rouquet P, Formenty P, Souquiere S, Kilbourne A, et al. (2004) Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science 303: 387-390.
6. CDC (2007) Ebola Hemorrhagic Fever Outbreak in Uganda. Available: http://www.cdc.gov/ncidod/dvrd/Spb/outbreaks/index.htm. Accessed 13 November 2012. Outbreak Postings.
7. CDC (2010) Known Cases and Outbreaks of Ebola Hemorrhagic Fever, in Chronological Order. Available at: http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/ebola/ebolatable.htm. [Accessed 13/11/2012]. CDC Special Pathogens Branch.
8. WHO (2008) Ebola outbreak contained in Uganda. Available: http://www.who.int/features/2008/ebola_outbreak/en/. Accessed 13 November 2012.
9. Formenty P, Hatz C, Le Guenno B, Stoll A, Rogenmoser P, et al. (1999) Human infection due to Ebola virus, subtype Cote d'Ivoire: clinical and biologic presentation. J Infect Dis 179Suppl 1: S48-53.
10. Le Guenno B, Formenty P, Wyers M, Gounon P, Walker F, et al. (1995) Isolation and partial characterisation of a new strain of Ebola virus. Lancet 345: 1271-1274.
11. WHO (1995) Ebola virus Available at: http: whqlibdoc.who.int wer = WHO_WER_1995. [Accessed 22/11/2010]. Weekly Epidemiological Record - Releve Epidemiologique Hebdomadaire 70: 137.
12. Fisher-Hoch SP, Brammer TL, Trappier SG, Hutwagner LC, Farrar BB, et al. (1992) Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain. J Infect Dis 166: 753-763.
13. Becker S, Feldmann H, Will C, Slenczka W, (1992) Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide? Med Microbiol Immunol 181: 43-55.
14. Rollin PE, Williams RJ, Bressler DS, Pearson S, Cottingham M, et al. (1999) Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis 179 Suppl 1: S108-114.
15. Miranda ME, Ksiazek TG, Retuya TJ, Khan AS, Sanchez A, et al. (1999) Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis 179 Suppl 1: S115-119.
16. Bausch DG, Feldmann H, Geisbert TW, Bray M, Sprecher AG, et al. (2007) Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient. J Infect Dis 196 Suppl 2: S136-141.
17. WHO (2005) Marburg haemorrhagic fever in Angola- update 25 (August 24, 2005). Available: http://www.who.int/csr/don/2005_08_24/en/index.html. Accessed 13 November 2012. Geneva.
18. Bausch DG, Borchert M, Grein T, Roth C, Swanepoel R, et al. (2003) Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. Emerg Infect Dis 9: 1531-1537.
19. Colebunders R, Tshomba A, Van Kerkhove MD, Bausch DG, Campbell P, et al. (2007) Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment. J Infect Dis 196 Suppl 2: S148-153.
20. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, Borchert M, Rollin PE, et al. (2006) Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med 355: 909-919.
21. Bausch DG, Sprecher AG, Jeffs B, Boumandouki P, (2008) Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. Antiviral Res 78: 150-161.
22. WHO (2008) Case of Marburg Haemorrhagic Fever imported into the Netherlands from Uganda. Available: http://www.who.int/csr/don/2008_07_10/en/index.html. Accessed 13 November 2012. Geneva.
23. WHO (2008) Ebola haemorrhagic fever in the Democratic Republic of the Congo. Available: http://www.who.int/csr/don/2008_12_26a/en/index.html. Accessed 13 November 2012. Geneva.
24. CDC (2009) Imported case of Marburg hemorrhagic fever - Colorado 2008. Morbidity and Mortality Weekly Report 58: 1377-1381.
25. Tuffs A, (2009) Experimental vaccine may have saved Hamburg scientist from Ebola fever. BMJ 338: b1223.
26. Roddy P, Colebunders R, Lim M, (in preparation) Filovirus hemorrhagic fever outbreak case management: a review of current and future treatment options. Journal of Infectious Disease.
27. WHO (2011) Ebola in Uganda. Available: http://www.who.int/csr/don/2011_05_18/en/index.html. Accessed 13 November 2012. Geneva.
28. Ndambi R, Akamituna P, Bonnet MJ, Tukadila AM, Muyembe-Tamfum JJ, et al. (1999) Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis 179 Suppl 1: S8-10.
29. Jeffs B, Roddy P, Weatherill D, de la Rosa O, Dorion C, et al. (2007) The Medecins Sans Frontieres intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005. I. Lessons learned in the hospital. J Infect Dis 196 Suppl 2: S154-161.
30. Baert B (2001) Ebola outbreak preparedness and management. Brussels: Médecins Sans Frontières Belgium.
31. Sterk E (2008) Filovirus haemorrhagic fever guidelines. Barcelona: Médecins Sans Frontières Operational Center Barcelona. 138 p.
32. Casillas AM, Nyamathi AM, Sosa A, Wilder CL, Sands H, (2003) A current review of Ebola virus: pathogenesis, clinical presentation, and diagnostic assessment. Biol Res Nurs 4: 268-275.
33. Roddy P, Thomas SL, Jeffs B, Nascimento Folo P, Pablo Palma P, et al. (2010) Factors associated with Marburg hemorrhagic fever: analysis of patient data from Uige, Angola. J Infect Dis 201: 1909-1918.
34. Grolla A, Jones SM, Fernando L, Strong JE, Stroher U, et al. (2011) The Use of a Mobile Laboratory Unit in Support of Patient Management and Epidemiological Surveillance during the 2005 Marburg Outbreak in Angola. PLoS Negl Trop Dis 5: e1183.
35. Bray M, Mahanty S, (2003) Ebola hemorrhagic fever and septic shock. J Infect Dis 188: 1613-1617.
36. Stroher U, Feldmann H, (2006) Progress towards the treatment of Ebola haemorrhagic fever. Expert Opin Investig Drugs 15: 1523-1535.
37. Zaki SR, Goldsmith CS, (1999) Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol 235: 97-116.
38. Davis KJ, Anderson AO, Geisbert TW, Steele KE, Geisbert JB, et al. (1997) Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells. Arch Pathol Lab Med 121: 805-819.
39. Jaax NK, Davis KJ, Geisbert TJ, Vogel P, Jaax GP, et al. (1996) Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 120: 140-155.
40. Sureau PH, (1989) Firsthand clinical observations of hemorrhagic manifestations in Ebola hemorrhagic fever in Zaire. Rev Infect Dis 11 Suppl 4: S790-793.
41. Georges AJ, Leroy EM, Renaut AA, Benissan CT, Nabias RJ, et al. (1999) Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. J Infect Dis 179 Suppl 1: S65-75.
42. Leroy EM, Souquiere S, Rouquet P, Drevet D, (2002) Re-emergence of ebola haemorrhagic fever in Gabon. Lancet 359: 712.
43. Kalongi Y, Mwanza K, Tshisuaka M, Lusiama N, Ntando E, et al. (1999) Isolated case of Ebola hemorrhagic fever with mucormycosis complications, Kinshasa, Democratic Republic of the Congo. J Infect Dis 179 Suppl 1: S15-17.
44. Kibadi K, Mupapa K, Kuvula K, Massamba M, Ndaberey D, et al. (1999) Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis 179 Suppl 1: S13-14.
45. Mupapa K, Mukundu W, Bwaka MA, Kipasa M, De Roo A, et al. (1999) Ebola hemorrhagic fever and pregnancy. J Infect Dis 179 Suppl 1: S11-12.
46. Mupapa K, Massamba M, Kibadi K, Kuvula K, Bwaka A, et al. (1999) Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis 179 Suppl 1: S18-23.
47. Bonnet MJ, Akamituna P, Mazaya A, (1998) Unrecognized Ebola hemorrhagic fever at Mosango Hospital during the 1995 epidemic in Kikwit, Democratic Republic of the Congo. Emerg Infect Dis 4: 508-510.
48. Bwaka MA, Bonnet MJ, Calain P, Colebunders R, De Roo A, et al. (1999) Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 179 Suppl 1: S1-7.
49. WHO (1978) Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 56: 271-293.
50. Isaacson M, Sureau P, Courteille G, Pattyn S (1978) Clinical aspects of Ebola virus disease at the Ngaliema hospital, Kinshasa, Zaire, 1976 In: Pattyn S, editor. Ebola virus hemorrhagic fever. Amsterdam: Elsevier/North Holland. pp. 15-20.
51. Piot P, Sureau P, Breman G (1978) Clinical aspects of Ebola virus infection in Yambuku area, Zaire, 1976. In: Pattyn SA, editor. Ebola virus hemorrhagic fever: Elsevier/North-Holland. pp. 7-14.
52. Heymann DL, Weisfeld JS, Webb PA, Johnson KM, Cairns T, et al. (1980) Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis 142: 372-376.
53. WHO (1978) Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ 56: 247-270.
54. Baron RC, McCormick JB, Zubeir OA, (1983) Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ 61: 997-1003.
55. Emond RT, Evans B, Bowen ET, Lloyd G, (1977) A case of Ebola virus infection. Br Med J 2: 541-544.
56. Mupere E, Kaducu OF, Yoti Z, (2001) Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations. Afr Health Sci 1: 60-65.
57. Siegert R, Shu HL, Slenczka W, Peters D, Muller G, (1967) [On the etiology of an unknown human infection originating from monkeys]. Dtsch Med Wochenschr 92: 2341-2343.
58. Martini GA, (1969) Marburg agent disease: in man. Trans R Soc Trop Med Hyg 63: 295-302.
59. Martini GA, Knauff HG, Schmidt HA, Mayer G, Baltzer G, (1968) A hitherto unknown infectious disease contracted from monkeys. "Marburg-virus" disease. Ger Med Mon 13: 457-470.
60. Martini G (1971) Marburg virus disease. Clinical syndrome. Marburg Virus Disease. New York: Springer-Verlag. pp. 1-9.
61. Egbring R, Slenczka W, Baltzer G (1971) Clinical manifestations and mechanism of the haemorrhagic diathesis in Marburg virus disease. Marburg Virus Disease. Berlin: Springer-Verlag. pp. 42-49.
62. Stille W, Bohle E (1971) Clinical course and prognosis of Marburg virus ("Green Monkey") disease. Marburg Virus Disease. Berlin: Spring-Verlag. pp. 10-18.
63. Todorovitch K, Mocitch M, Klasnja R (1971) Clinical picture of two patients infected by the Marburg vervet virus. Marburg Virus Disease. Berlin: Springer-Verlag. pp. 19-23.
64. Nikiforov VV, Turovskii Iu I, Kalinin PP, Akinfeeva LA, Katkova LR, et al. (1994) [A case of a laboratory infection with Marburg fever]. Zh Mikrobiol Epidemiol Immunobiol: 104-106.
65. Johnson ED, Johnson BK, Silverstein D, Tukei P, Geisbert TW, et al. (1996) Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol Suppl 11: 101-114.
66. Smith DH, Johnson BK, Isaacson M, Swanapoel R, Johnson KM, et al. (1982) Marburg-virus disease in Kenya. Lancet 1: 816-820.
67. Gear JS, Cassel GA, Gear AJ, Trappler B, Clausen L, et al. (1975) Outbreak of Marburg virus disease in Johannesburg. Br Med J 4: 489-493.
68. WHO (2007) Ebola haemorrhagic fever in Uganda. Available: http://www.who.int/csr/don/2007_11_30a/en/index.html. Accessed 13 November 2012. Geneva.
69. MacNeil A, Farnon EC, Wamala J, Okware S, Cannon DL, et al. (2010) Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg Infect Dis 16: 1969-1972.
70. WHO (2007) End of Ebola outbreak in Uganda. Available: http://www.who.int/csr/don/2007_02_20b/en/index.html. Accessed 13 November 2012. Geneva.
71. Towner JS, Sealy TK, Khristova ML, Albarino CG, Conlan S, et al. (2008) Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog 4: e1000212.
72. WHO (2004) WHO announces end of Ebola outbreak in southern Sudan. Available: http://www.who.int/csr/don/2004_08_07/en/index.html. Accessed 13 November 2012. Geneva.
73. WHO (2008) End of Ebola outbreak in the Democratic Republic of the Congo. Available: http://www.who.int/csr/don/2009_02_17/en/index.html. Accessed 13 November 2012. Geneva.
74. Borchert M, Muyembe-Tamfum JJ, Colebunders R, Libande M, Sabue M, et al. (2002) Short communication: a cluster of Marburg virus disease involving an infant. Trop Med Int Health 7: 902-906.
75. Dowell SF, (1996) Ebola hemorrhagic fever: why were children spared? Pediatr Infect Dis J 15: 189-191.
76. Roels TH, Bloom AS, Buffington J, Muhungu GL, Mac Kenzie WR, et al. (1999) Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis 179 Suppl 1: S92-97.
77. Francesconi P, Yoti Z, Declich S, Onek PA, Fabiani M, et al. (2003) Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis 9: 1430-1437.
78. Hewlett BS, Amola RP, (2003) Cultural contexts of Ebola in northern Uganda. Emerg Infect Dis 9: 1242-1248.
79. Conrad JL, Isaacson M, Smith EB, Wulff H, Crees M, et al. (1978) Epidemiologic investigation of Marburg virus disease, Southern Africa, 1975. Am J Trop Med Hyg 27: 1210-1215.
80. Bray M, Murphy FA, (2007) Filovirus research: knowledge expands to meet a growing threat. J Infect Dis 196 Suppl 2: S438-443.
81. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, et al. (2007) Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 196 Suppl 2: S142-147.
82. Buhler S (2008) Health care workers' experiences and preferences regarding documentation of clinical data and its transference from Ebola and Marburg wards (MSc thesis). London: London School of Hygiene & Tropical Medicine.